Floatz logo

Enalapril

Proteinuria

University of Alabama at BirminghamSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Proteinuria cohort.

Asset / SponsorPhaseRating
VALSARTAN
Columbia University
Phase 4BB
Semaglutide
University Medical Center Groningen
Phase 3BB
Aliskiren
Columbia University
Phase 4CCC
Losartan
University of Alabama at Birmingham
Phase 2CCC
Empagliflozin
University of Illinois at Chicago
Phase 2CCC
Huaier Granule
Fudan University
Phase 2CCC
Paricalcitol
Federico II University
N/AD

Same molecule, other indications

Enalapril is also rated in:

essential hypertensionDormant
BB
Indicative ·
67 / 100
View asset →
hypertensive disorderDormant
BB
Indicative ·
65 / 100
View asset →
diabetes mellitusDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →